BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1370207)

  • 1. Localization of the platelet-specific HPA-2 (Ko) alloantigens on the N-terminal globular fragment of platelet glycoprotein Ib alpha.
    Kuijpers RW; Ouwehand WH; Bleeker PM; Christie D; von dem Borne AE
    Blood; 1992 Jan; 79(1):283-8. PubMed ID: 1370207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human anti-PlE1 antibody recognizes epitopes associated with the alpha subunit of platelet glycoprotein Ib.
    Furihata K; Hunter J; Aster RH; Koewing GR; Shulman NP; Kunicki TJ
    Br J Haematol; 1988 Jan; 68(1):103-10. PubMed ID: 2449905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet sensitivity to ristocetin is predicted by the binding characteristics of a GPIb/IX determinant.
    Miller JL; Hustad KO; Kupinski JM; Lyle VA; Kunicki TJ
    Br J Haematol; 1990 Mar; 74(3):313-9. PubMed ID: 1692230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen.
    Ruan CG; Du XP; Xi XD; Castaldi PA; Berndt MC
    Blood; 1987 Feb; 69(2):570-7. PubMed ID: 3801672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil cathepsin G modulates the platelet surface expression of the glycoprotein (GP) Ib-IX complex by proteolysis of the von Willebrand factor binding site on GPIb alpha and by a cytoskeletal-mediated redistribution of the remainder of the complex.
    LaRosa CA; Rohrer MJ; Benoit SE; Barnard MR; Michelson AD
    Blood; 1994 Jul; 84(1):158-68. PubMed ID: 7517206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex.
    De Marco L; Mazzucato M; Fabris F; De Roia D; Coser P; Girolami A; Vicente V; Ruggeri ZM
    J Clin Invest; 1990 Jul; 86(1):25-31. PubMed ID: 1694864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex.
    Berndt MC; Du XP; Booth WJ
    Biochemistry; 1988 Jan; 27(2):633-40. PubMed ID: 2450575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens.
    Kuijpers RW; Faber NM; Cuypers HT; Ouwehand WH; von dem Borne AE
    J Clin Invest; 1992 Feb; 89(2):381-4. PubMed ID: 1346615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ib alpha leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease.
    Miller JL; Lyle VA; Cunningham D
    Blood; 1992 Jan; 79(2):439-46. PubMed ID: 1730088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
    Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
    Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets.
    Nishio K; Fujimura Y; Niinomi K; Takahashi Y; Yoshioka A; Fukui H; Usami Y; Titani K; Ruggeri ZM; Zimmerman TS
    Am J Hematol; 1990 Apr; 33(4):261-6. PubMed ID: 2316510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
    Obert B; Houllier A; Meyer D; Girma JP
    Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane.
    Berndt MC; Gregory C; Kabral A; Zola H; Fournier D; Castaldi PA
    Eur J Biochem; 1985 Sep; 151(3):637-49. PubMed ID: 3161731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism.
    Ulrichts H; Vanhoorelbeke K; Cauwenberghs S; Vauterin S; Kroll H; Santoso S; Deckmyn H
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1302-7. PubMed ID: 12775575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human platelet-specific antigen, Siba, is associated with the molecular weight polymorphism of glycoprotein Ib alpha.
    Ishida F; Saji H; Maruya E; Furihata K
    Blood; 1991 Oct; 78(7):1722-9. PubMed ID: 1912562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib.
    Katagiri Y; Hayashi Y; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
    Thromb Haemost; 1990 Feb; 63(1):122-6. PubMed ID: 2339348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor.
    Coller BS; Peerschke EI; Scudder LE; Sullivan CA
    Blood; 1983 Jan; 61(1):99-110. PubMed ID: 6336654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib.
    Peng M; Lu W; Kirby EP
    Biochemistry; 1991 Dec; 30(49):11529-36. PubMed ID: 1747371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.